ENANTA PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q4 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Enanta Pharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from Q4 2019 to Q1 2022.
  • Enanta Pharmaceuticals Inc Operating Lease, Payments for the quarter ending May 12, 2022 was $76.5K.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2024 was $8.28M, a 25.8% increase from 2023.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $6.59M, a 32.6% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $4.97M, a 22% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $76.5K May 12, 2022 10-Q 2022-08-08
Q3 2020 $4.13M $1.23M Jul 1, 2020 Sep 30, 2020 10-K 2021-11-24
Q2 2020 $1.11M Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.05M Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $736K Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.